Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00857662 · ClinicalTrials.gov registry record · Phase 2
Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs)
A Phase 2 study, sponsored by Medtronic Neurovascular Clinical Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 117
- Enrollment target
NCT00857662: Completed Phase 2 study, sponsored by Medtronic Neurovascular Clinical Affairs.
NCT00857662 is a Phase 2 study that has completed, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 117 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (12% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00857662, a Phase 2 study, has completed, sponsored by Medtronic Neurovascular Clinical Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 117 participants
- Enrollment target
Study Summary
Test whether AVMs treated with Onyx is equivalent to treatment with n-BCA. Success is defined as an AVM size reduction greater than 50%
Interventions
- DEVICE Onyx
- DEVICE TRUFILL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2001-05 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
What the finished NCT00857662 record still lists
NCT00857662 is an interventional study that assigns participants to a tested intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (12% lower).
The record links to 0 conditions, and to 2 interventions - of which Onyx is the first listed.
NCT00857662 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00857662 about?
NCT00857662 is a clinical study titled "Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs)". Test whether AVMs treated with Onyx is equivalent to treatment with n-BCA. Success is defined as an AVM size reduction greater than 50%
What is the current status of trial NCT00857662?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 117 participants. The study started on 2001-05. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00857662?
The interventions under investigation include: Onyx (DEVICE), TRUFILL (DEVICE).
Who is sponsoring clinical trial NCT00857662?
This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00857662's enrollment target sits among peer trials
117 623rd of 2000 higher than 1,378 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia